The commonest cause of primary amenorrhea with ambiguous genitalia in a female with 46XX chromosome :
**Core Concept**
21-hydroxylase deficiency is a congenital adrenal hyperplasia (CAH) disorder characterized by impaired cortisol production, leading to an overproduction of androgens. This results in virilization of female genitalia, manifesting as ambiguous genitalia in affected individuals.
**Why the Correct Answer is Right**
In 21-hydroxylase deficiency, the blockage occurs in the conversion of 17-hydroxyprogesterone (17-OHP) to 11-deoxycortisol in the late steps of the steroidogenesis pathway. As a result, the adrenal glands produce excessive amounts of androgens, such as testosterone and dihydrotestosterone (DHT), causing virilization of the external genitalia in females. The enzyme deficiency leads to an accumulation of 17-OHP, which is then shunted towards androgen production. This results in the characteristic ambiguous genitalia in affected females.
**Why Each Wrong Option is Incorrect**
**Option B:** 17-hydroxylase deficiency is characterized by a deficiency in the conversion of pregnenolone to 17-hydroxypregnenolone. This results in a decrease in cortisol and sex hormone production, leading to hypogonadism and hypertension, not virilization.
**Option C:** 11-hydroxylase deficiency is another type of CAH, where the blockage occurs in the conversion of 11-deoxycortisol to cortisol. This results in an overproduction of 11-deoxycortisol, which has mineralocorticoid activity, leading to hypertension and hypokalemia, but not virilization.
**Option D:** Desmolase hydrolase deficiency (also known as 20,22-desmolase deficiency) is a rare form of CAH, where the blockage occurs in the conversion of cholesterol to pregnenolone. This results in a decrease in cortisol and sex hormone production, leading to hypogonadism and adrenal insufficiency, but not virilization.
**Clinical Pearl / High-Yield Fact**
The classic presentation of 21-hydroxylase deficiency includes ambiguous genitalia in females, early pubic hair, and short stature. The diagnosis is confirmed by demonstrating elevated 17-OHP levels and decreased cortisol levels in a 17-hydroxyprogesterone stimulation test.
**✓ Correct Answer: A. 21 hydroxylase def.**